Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3761721010 | Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3761722015 | Product containing precisely calcium carbonate 800 milligram and famotidine 10 milligram and magnesium hydroxide 165 milligram/1 each conventional release chewable tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | Is a | Product containing calcium carbonate and famotidine and magnesium hydroxide (medicinal product) | false | Inferred relationship | Some | ||
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | Has active ingredient | Laxative (substance) | false | Inferred relationship | Some | ||
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | Has active ingredient | Magnesium | false | Inferred relationship | Some | ||
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | Has active ingredient | Trace element supplementation | false | Inferred relationship | Some | ||
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | Has active ingredient | Famotidine (substance) | false | Inferred relationship | Some | ||
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | Has active ingredient | Magnesium hydroxide (substance) | false | Inferred relationship | Some | ||
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | Has active ingredient | Magnesium-based antacid | false | Inferred relationship | Some | ||
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | Has active ingredient | Calcium carbonate (substance) | false | Inferred relationship | Some | ||
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Some | ||
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | Has manufactured dose form | Oral tablet | false | Inferred relationship | Some | ||
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | Is a | Famotidine-containing product in oral dose form | false | Inferred relationship | Some | ||
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | Has manufactured dose form | Chewable tablet | true | Inferred relationship | Some | ||
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | Is a | Product containing calcium carbonate in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Some | ||
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | Count of base of active ingredient | 3 (kwalificatiewaarde) | false | Inferred relationship | Some | ||
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | Plays role | Laxative therapeutic role | false | Inferred relationship | Some | ||
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | Has presentation strength denominator value | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | 1 | |
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 3 | |
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | Has presentation strength denominator value | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | 2 | |
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | Has presentation strength denominator value | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | 3 | |
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some | ||
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 3 | |
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 2 | |
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | Is a | Product containing only calcium carbonate and famotidine and magnesium hydroxide in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | Has basis of strength substance (attribute) | Magnesium hydroxide (substance) | true | Inferred relationship | Some | 3 | |
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | Has precise active ingredient | Magnesium hydroxide (substance) | true | Inferred relationship | Some | 3 | |
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | Has precise active ingredient | Famotidine (substance) | true | Inferred relationship | Some | 1 | |
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | Has presentation strength numerator value | 10 (kwalificatiewaarde) | false | Inferred relationship | Some | 1 | |
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | Has precise active ingredient | Calcium carbonate (substance) | true | Inferred relationship | Some | 2 | |
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | Has basis of strength substance (attribute) | Famotidine (substance) | true | Inferred relationship | Some | 1 | |
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | Has basis of strength substance (attribute) | Calcium carbonate (substance) | true | Inferred relationship | Some | 2 | |
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | Has presentation strength numerator value | 165 | false | Inferred relationship | Some | 3 | |
| Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet | Has presentation strength numerator value | 800 (kwalificatiewaarde) | false | Inferred relationship | Some | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR